Fig. 4From: Discovery of dual rho-associated protein kinase 1 (ROCK1)/apoptosis signal–regulating kinase 1 (ASK1) inhibitors as a novel approach for non-alcoholic steatohepatitis (NASH) treatmentThe overall performance of the different pharmacophore models based on their Mathew’s correlation coefficient (MCC) valuesBack to article page